Cargando…

Selection and Validation of Induction Chemotherapy Beneficiaries Among Patients With T3N0, T3N1, T4N0 Nasopharyngeal Carcinoma Using Epstein-Barr Virus DNA: A Joint Analysis of Real-World and Clinical Trial Data

Background and Purpose: Evidence for induction chemotherapy plus concurrent chemoradiotherapy (IC+CCRT) in nasopharyngeal carcinoma (NPC) was derived from landmark clinical trials excluding the T3N0, T3N1, T4N0 subgroups. This study used Epstein-Barr virus (EBV) DNA to select IC beneficiaries from t...

Descripción completa

Detalles Bibliográficos
Autores principales:	Xu, Cheng, Zhang, Shu, Li, Wen-Fei, Chen, Lei, Mao, Yan-Ping, Guo, Ying, Liu, Qing, Ma, Jun, Tang, Ling-Long
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2019
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6896227/ https://www.ncbi.nlm.nih.gov/pubmed/31850226 http://dx.doi.org/10.3389/fonc.2019.01343

Ejemplares similares

Development and validation of radiologic scores for guiding individualized induction chemotherapy in T3N1M0 nasopharyngeal carcinoma
por: Yang, Shan-Shan, et al.
Publicado: (2022)

Explore the Value of Adding Induction Chemotherapy to Concurrent Chemoradiotherapy in T3-4N0M0 Nasopharyngeal Carcinoma Patients: A Retrospective Study
por: Li, Peijing, et al.
Publicado: (2021)

The efficacy of induction chemotherapy or adjuvant chemotherapy added to concurrent chemoradiotherapy in T3-4N0-1M0 nasopharyngeal carcinoma: a propensity score-matched analysis
por: Zhong, Qiulu, et al.
Publicado: (2023)

Explore the Value of Adding Induction Chemotherapy to Concurrent Chemoradiotherapy in T3-4N0M0 Nasopharyngeal Carcinoma Patients: A Retrospective Study [Corrigendum]
Publicado: (2022)

Outcomes of adding induction chemotherapy to concurrent chemoradiotherapy for stage T3N0-1 nasopharyngeal carcinoma: a propensity-matched study
por: Lan, Xiao-Wen, et al.
Publicado: (2017)

Comparison of T2N0M0 and T3aN0M0 in Predicting the Prognosis of Patients With Renal Cell Carcinoma
por: He, Xiaobo, et al.
Publicado: (2020)

T(1-2)N(1)M(0) nasopharyngeal carcinoma chemotherapy or not: A retrospective study
por: Li, Pei-Jing, et al.
Publicado: (2023)

Individualized induction chemotherapy by pre-treatment plasma Epstein-Barr viral DNA in advanced nasopharyngeal carcinoma
por: Zhang, Jian, et al.
Publicado: (2018)

Indication for and Effect of Adjuvant Chemotherapy for Stage IIa (T3N0M0) Colon Cancer
por: Jeon, Chul-Hyo, et al.
Publicado: (2019)

Prognostic factors of T2aN0M0 (T3‐4cmN0M0, stage IB) non‐small‐cell lung cancer after surgery: Single‐center real‐world research
por: Liu, Lei, et al.
Publicado: (2021)

The role of chemotherapy in patients with T1bN0M0 triple-negative breast cancer: a real-world competing risk analysis
por: Lan, Tian, et al.
Publicado: (2021)

Is Adjuvant Chemotherapy Beneficial to All Patients With pT3N0M0 Stage Gastric Cancer?
por: Huang, Jiao-Bao, et al.
Publicado: (2021)

Reactive Oxygen Species Mediate Epstein-Barr Virus Reactivation by N-Methyl-N’-Nitro-N-Nitrosoguanidine
por: Huang, Sheng-Yen, et al.
Publicado: (2013)

Epstein-Barr virus and nasopharyngeal carcinoma
por: Young, Lawrence S., et al.
Publicado: (2014)

Indications for adjuvant chemotherapy in patients with AJCC stage IIa T3N0M0 and T1N2M0 gastric cancer—an east and west multicenter study
por: Huang, Ze-Ning, et al.
Publicado: (2019)

Impact of duration of adjuvant chemotherapy in radically resected patients with T4bN1-3M0/TxN3bM0 gastric cancer
por: Wang, Qi-Wei, et al.
Publicado: (2018)

Prognostic effect of residual plasma Epstein–Barr viral DNA after induction chemotherapy for locoregionally advanced nasopharyngeal carcinoma
por: Zheng, Hua, et al.
Publicado: (2023)

Role of surgery in T4N0-3M0 esophageal cancer
por: Qi, Chen, et al.
Publicado: (2023)

Prognostic value of chemotherapy in addition to concurrent chemoradiotherapy in T3-4N0-1 nasopharyngeal carcinoma: a propensity score matching study
por: Wu, Li-Rong, et al.
Publicado: (2017)

The reactions $K^{-}$ n -> $K^{*-}$ n and $K^{-}$ n -> $\overline{K}^{0}$ $N^{*-}$ at 3 GeV/c
por: Bakker, G, et al.
Publicado: (1970)

Crystalline C(3)N(3)H(3) tube (3,0) nanothreads
por: Gao, Dexiang, et al.
Publicado: (2022)

A Real-World Study of Prognosis of N0M0 Hepatocellular Carcinoma with Hepatic Resection Based on SEER Database
por: Zhu, Guangxi, et al.
Publicado: (2020)

The efficacy and toxicities of intensive induction chemotherapy followed by concurrent chemoradiotherapy in nasopharyngeal carcinoma patients with N(3) disease
por: Zhang, Yingying, et al.
Publicado: (2017)

Can Epstein–Barr virus‐deoxyribonucleic acid load after induction chemotherapy combined with American Joint Committee on Cancer stage determine the chemotherapy intensity of locally advanced nasopharyngeal carcinoma?
por: Zhang, Qun, et al.
Publicado: (2022)

Targeting Epstein-Barr Virus in Nasopharyngeal Carcinoma
por: Hau, Pok Man, et al.
Publicado: (2020)

The role of Epstein–Barr virus in nasopharyngeal carcinoma
por: Su, Zhi Yi, et al.
Publicado: (2023)

Epstein–Barr Virus BALF0 and BALF1 Modulate Autophagy
por: Shao, Zhouwulin, et al.
Publicado: (2019)

High-Temperature Ferroelectric Behavior of Al(0.7)Sc(0.3)N
por: Drury, Daniel, et al.
Publicado: (2022)

A new determination of the capture ratio : $\gamma$ 0 = $\sigma^{-}$ p -> $\sigma^{0}$ n / ( $\sigma^{-}$ p -> $\sigma^{0}$ n ) + ( $\sigma^{-}$ p -> $\lambda^{0}$ n )
por: Hepp, V, et al.
Publicado: (1968)

Long-term outcomes of induction chemotherapy followed by intensity-modulated radiotherapy and adjuvant chemotherapy in nasopharyngeal carcinoma patients with N3 disease
por: Niu, Xiaoshuang, et al.
Publicado: (2021)

Role of adjuvant chemotherapy in locally advanced rectal cancer with ypT0-3N0 after preoperative chemoradiation therapy and surgery
por: Kim, Chang Gon, et al.
Publicado: (2017)

Survival benefit of perioperative chemotherapy for T1–3N0M0 stage esophageal cancer: a SEER database analysis
por: Shao, Yue, et al.
Publicado: (2021)

Optimal cumulative cisplatin dose in nasopharyngeal carcinoma patients based on plasma Epstein–Barr virus DNA level after induction chemotherapy
por: Liu, Sai-Lan, et al.
Publicado: (2020)

Radiotherapy Alone Versus Concurrent or Adjuvant Chemoradiotherapy for Nasopharyngeal Carcinoma Patients with Negative Epstein–Barr Virus DNA after Induction Chemotherapy
por: Kong, Fangfang, et al.
Publicado: (2023)

N-type organic thermoelectrics: demonstration of ZT > 0.3
por: Liu, Jian, et al.
Publicado: (2020)

Pontecorvo reactions in antiproton annihilation at rest in deuterium to $\pi^{0}n, \pi^{0} \Delta^{0}, \eta n$ and $\eta \Delta^{0}$
por: Chiba, M, et al.
Publicado: (1997)

First measurement of $D_{0n0n}$ in $\overline{p}p$ elastic scattering
por: Künne, R A, et al.
Publicado: (1991)

The evolution of Epstein-Barr virus detection in nasopharyngeal carcinoma
por: Li, You Quan, et al.
Publicado: (2018)

Role of Epstein-Barr Virus in the Development of Nasopharyngeal Carcinoma
por: Zhang, Hui, et al.
Publicado: (2017)

Charge exchange and the reaction $p + p \rightarrow n + n +\pi^{+} + \pi^{-}$ of 3.0, 3.6 and 4.0 GeV/c antiprotons
por: Czyzewski, O, et al.
Publicado: (1966)

Cannot write session to /tmp/vufind_sessions/sess_9h02imsj0tua0tcls17hpk68re